Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Methanesulfonic Acid | HCID 6395 | — |
| Reactant | 2-Pentanone | HCID 7895 | — |
| Reactant | Nelfinavir | HCID 64143 | — |
| Solvent | Acetone | HCID 180 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Solvent | Methyl Ethyl Ketone | HCID 6569 | — |
| Solvent | Methyl Isobutyl Ketone | HCID 7909 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Nelfinavir Mesylate | HCID 64142 | — |
Reaction Steps
Thus in accordance to the present invention Nelfinavir base is suspended in an organic solvent, selected from methanol, ethanol, isopropanol, THF, and methanesulfonic acid is added at temperature below 45° C. over a period of 10 min to 4 hrs. The reaction mass is mixed for about 15 min to 4 hrs to form a solution and then cooled to 10° C. to 35° C. A ketone such as acetone, methyl ethyl ketone, methyl isobutyl ketone, 2-pentanone is added as ante solvent at temperature 10° C. to about 35° C. in about 15 min to 4 hrs. The resulting reaction mass is maintained at temperature of 10° C. to 35° C. for about 30 min to 6 hrs then cooled and maintained at temperature of −10° C. to 15° C. for about 30 min to 4 hrs. The precipitated solid is separated and dried at temperature of 50° C. to 120° C., preferably at 80° C. to 110° C. under reduced pressure to produce novel crystalline forms of Nelfinavir mesylate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08367832B2 |
|---|
| Source dataset | uspto-grants-2013_02 |
|---|
| ORD ID | ord-40481b481c004547be741942f60be281 |
|---|
| Source note | uspto-grants-2013_02 |
|---|